Showing results (441-450 of 478) with videos related to
Sort By:
Pageof 48
Blood|February 17, 2005
Leukemias following retroviral transfer of multidrug resistance 1 (MDR1) are driven by combinatorial insertional mutagenesisUte Modlich, Olga S Kustikova, Manfred Schmidt, et al.British Journal of Haematology|March 17, 2020
Measurable residual disease assessment by qPCR in peripheral blood is an informative tool for disease surveillance in childhood acute myeloid leukaemiaKristian Løvvik Juul-Dam, Hans B Ommen, Charlotte G Nyvold, et al.Clinical Pharmacology and Therapeutics|April 7, 2022
Regulation of Drug Transport Proteins-From Mechanisms to Clinical Impact: A White Paper on Behalf of the International Transporter ConsortiumKim L R Brouwer, Raymond Evers, Elizabeth Hayden, et al.Clinical and Translational Medicine|November 2, 2022
Circulating cell-free messenger RNA enables non-invasive pan-tumour monitoring of melanoma therapy independent of the mutational genotypeLea Jessica Albrecht, Anna Höwner, Klaus Griewank, et al.American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics|December 25, 2010
Mapping for dyslexia and related cognitive trait loci provides strong evidence for further risk genes on chromosome 6p21Inke R König, Johannes Schumacher, Per Hoffmann, et al.Cancers|March 6, 2021
Second Relapse of Pediatric Patients with Acute Myeloid Leukemia: A Report on Current Treatment Strategies and Outcome of the AML-BFM Study GroupMareike Rasche, Emma Steidel, Martin Zimmermann, et al.European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|February 25, 2026
Application of modelling of cell monolayer permeation data to generate input parameters compatible with in vitro-in vivo translation of blood-brain-barrier disposition of drugsJanita Hogan, Yukiko Murata, Zubida M Al-Majdoub, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 2, 2024
Influence of Nucleophosmin (NPM1) Genotypes on Outcome of Patients With AML: An AIEOP-BFM and COG-SWOG Intergroup CollaborationClaudia Tregnago, Maddalena Benetton, Rhonda E Ries, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 22, 2010
Granulocyte colony-stimulating factor (G-CSF) treatment of childhood acute myeloid leukemias that overexpress the differentiation-defective G-CSF receptor isoform IV is associated with a higher incidence of relapseStephanie Ehlers, Christin Herbst, Martin Zimmermann, et al.Eclinicalmedicine|June 16, 2025
No evidence of leukaemia (NEL) as a response criteria in paediatric AML: a multicentre analysisEvangelia Antoniou, Annika Puschnig, Naghmeh Niktoreh, et al.Pageof 48